Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis
In: Molecular Therapy, Jg. 26 (2018), Heft 1, S. 256-268
academicJournal
Zugriff:
Titel: |
Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis
|
---|---|
Autor/in / Beteiligte Person: | Le Meur, Guylène ; Lebranchu, Pierre ; Billaud, Fanny ; Adjali, Oumeya ; Schmitt, Sébastien ; Bézieau, Stéphane ; Péréon, Yann ; Valabregue, Romain ; Ivan, Catherine ; Darmon, Christophe ; Moullier, Philippe ; Rolling, Fabienne ; Weber, Michel ; AFM-Téléthon (Association Française contre les Myopathies) |
Link: | |
Zeitschrift: | Molecular Therapy, Jg. 26 (2018), Heft 1, S. 256-268 |
Veröffentlichung: | Elsevier BV, 2018 |
Medientyp: | academicJournal |
ISSN: | 1525-0016 |
DOI: | 10.1016/j.ymthe.2017.09.014 |
Schlagwort: |
|
Sonstiges: |
|